The Board of Directors of bioMerieux, a world leader in the field of in vitro diagnostics, met today to approve the consolidated financial statements for the six months ended June 30, 2011. The meeting was chaired by Jean-Luc Belingard and attended by the Statutory Auditors, who had performed a limited review of the financial statements.
bioMérieux has today acquired the entire capital and voting rights of Skiva (441 886 728 R.C.S. Paris), the parent company of the AES Chemunex group.
bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has acquired ARGENE, a French company specialized in molecular diagnostics. This acquisition is bioMérieux’s tenth in the last five years.
bioMerieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2011.
VIDAS® UP Recombinant Phage Technology Delivers Unprecedented Specificity and Sensitivity for Rapid and Reliable Testing
The International Association for Food Protection (IAFP) selected bioMerieux, Inc., as the 2011 recipient of the prestigious Black Pearl Award. Sponsored by Wilbur Feagan and F & H Food Equipment Company, the Black Pearl Award will be presented at IAFP's Annual Meeting in Milwaukee, Wisconsin in August.
AOAC Official Methods(SM) Approval Underscores VIDAS® Excellence in Food Safety Testing
bioMérieux, a world leader in the field of in vitro diagnostics, announced today that the VIDAS® Staphylococcal enterotoxins assay (SET2) has been included in the United States Food and Drug Administration’s (FDA) Bacteriological Analytical Manual (BAM) for food safety testing. The FDA’s BAM is recommending that the VIDAS SET2 protocol be used as the primary screening method for the presence of Staphylococcal enterotoxins in suspect food samples and culture isolates.
Company Offers Most Comprehensive, Cost-Effective Suite of Solutions to Detect and Screen for Methicillin Resistant Staphylococcus aureus (MRSA)
bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce Melvin Weinstein, M.D., as the 2011 recipient of the bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology.
